{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:31:28Z","timestamp":1777962688251,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82173840"],"award-info":[{"award-number":["82173840"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81973351"],"award-info":[{"award-number":["81973351"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017616","name":"Beijing Talents Foundation","doi-asserted-by":"crossref","award":["2017000021223TD03"],"award-info":[{"award-number":["2017000021223TD03"]}],"id":[{"id":"10.13039\/501100017616","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Municipal Health Commission Fund","award":["PXM2020_026283_000005"],"award-info":[{"award-number":["PXM2020_026283_000005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s13402-023-00842-5","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T19:01:37Z","timestamp":1688756497000},"page":"1747-1762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK"],"prefix":"10.1007","volume":"46","author":[{"given":"Weihua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huantong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihe","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"issue":"1","key":"842_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11060-020-03448-1","volume":"151","author":"R Medikonda","year":"2021","unstructured":"R. Medikonda, G. Dunn, M. Rahman, P. Fecci, M. Lim, A review of glioblastoma immunotherapy. J. Neurooncol. 151(1), 41\u201353 (2021)","journal-title":"J. Neurooncol."},{"issue":"14","key":"842_CR2","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1158\/1078-0432.CCR-18-1627","volume":"25","author":"W Tomaszewski","year":"2019","unstructured":"W. Tomaszewski, L. Sanchez-Perez, T.F. Gajewski, J.H. Sampson, Brain Tumor Microenvironment and Host State: Implications for Immunotherapy. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 25(14), 4202\u20134210 (2019)","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"842_CR3","doi-asserted-by":"crossref","unstructured":"V. Rajaratnam, M.M. Islam, M. Yang, R. Slaby, H.M. Ramirez, S.P. Mirza, Glioblastoma: Pathogenesis and current status of chemotherapy and other novel treatments. Cancers (Basel).\u00a012(4):937 (2020)","DOI":"10.3390\/cancers12040937"},{"issue":"1","key":"842_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13014-021-01767-9","volume":"16","author":"G Minniti","year":"2021","unstructured":"G. Minniti, M. Niyazi, F. Alongi, P. Navarria, C. Belka, Current status and recent advances in reirradiation of glioblastoma. Radiat. Oncol. (London, England) 16(1), 36 (2021)","journal-title":"Radiat. Oncol. (London, England)"},{"issue":"6","key":"842_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1159\/000091032","volume":"69","author":"S Li","year":"2005","unstructured":"S. Li, T. Tokuyama, J. Yamamoto, M. Koide, N. Yokota, H. Namba, Potent bystander effect in suicide gene therapy using neural stem cells transduced with herpes simplex virus thymidine kinase gene. Oncology 69(6), 503\u2013508 (2005)","journal-title":"Oncology"},{"issue":"8","key":"842_CR6","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1089\/hum.2009.042","volume":"21","author":"E Preuss","year":"2010","unstructured":"E. Preuss, A. Treschow, S. Newrzela, D. Br\u00fccher, K. Weber, U. Felldin, E. Alici, G. Gahrton, D. von Laer, M.S. Dilber et al., TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy. Hum. Gene Ther. 21(8), 929\u2013941 (2010)","journal-title":"Hum. Gene Ther."},{"issue":"11","key":"842_CR7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00109-011-0777-8","volume":"89","author":"E Preuss","year":"2011","unstructured":"E. Preuss, A. Muik, K. Weber, J. Otte, D. von Laer, B. Fehse, Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect. J. Mol. Med. (Berl) 89(11), 1113\u20131124 (2011)","journal-title":"J. Mol. Med. (Berl)"},{"issue":"7","key":"842_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/sj.cgt.7700826","volume":"12","author":"S Li","year":"2005","unstructured":"S. Li, T. Tokuyama, J. Yamamoto, M. Koide, N. Yokota, H. Namba, Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells. Cancer Gene Ther. 12(7), 600\u2013607 (2005)","journal-title":"Cancer Gene Ther."},{"issue":"17","key":"842_CR9","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1089\/104303400750038499","volume":"11","author":"NG Rainov","year":"2000","unstructured":"N.G. Rainov, A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther. 11(17), 2389\u20132401 (2000)","journal-title":"Hum. Gene Ther."},{"issue":"23","key":"842_CR10","doi-asserted-by":"publisher","first-page":"12846","DOI":"10.1073\/pnas.97.23.12846","volume":"97","author":"KS Aboody","year":"2000","unstructured":"K.S. Aboody, A. Brown, N.G. Rainov, K.A. Bower, S. Liu, W. Yang, J.E. Small, U. Herrlinger, V. Ourednik, P.M. Black et al., Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl. Acad. Sci. U.S.A. 97(23), 12846\u201312851 (2000)","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10","key":"842_CR11","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/sctm.18-0003","volume":"7","author":"R Mooney","year":"2018","unstructured":"R. Mooney, M. Hammad, J. Batalla-Covello, A. Abdul Majid, K.S. Aboody, Concise review: neural stem cell-mediated targeted cancer therapies. Stem Cells Transl. Med. 7(10), 740\u2013747 (2018)","journal-title":"Stem Cells Transl. Med."},{"issue":"12","key":"842_CR12","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/1541-7786.MCR-08-0146","volume":"6","author":"D Zhao","year":"2008","unstructured":"D. Zhao, J. Najbauer, E. Garcia, M.Z. Metz, M. Gutova, C.A. Glackin, S.U. Kim, K.S. Aboody, Neural stem cell tropism to glioma: critical role of tumor hypoxia. Mol. Cancer Res.: MCR 6(12), 1819\u20131829 (2008)","journal-title":"Mol. Cancer Res.: MCR"},{"issue":"12","key":"842_CR13","doi-asserted-by":"publisher","first-page":"983","DOI":"10.5966\/sctm.2012-0177","volume":"2","author":"MZ Metz","year":"2013","unstructured":"M.Z. Metz, M. Gutova, S.F. Lacey, Y. Abramyants, T. Vo, M. Gilchrist, R. Tirughana, L.Y. Ghoda, M.E. Barish, C.E. Brown et al., Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use. Stem Cells Transl. Med. 2(12), 983\u2013992 (2013)","journal-title":"Stem Cells Transl. Med."},{"issue":"184","key":"842_CR14","doi-asserted-by":"publisher","first-page":"184ra159","DOI":"10.1126\/scitranslmed.3005365","volume":"5","author":"KS Aboody","year":"2013","unstructured":"K.S. Aboody, J. Najbauer, M.Z. Metz, M. D\u2019Apuzzo, M. Gutova, A.J. Annala, T.W. Synold, L.A. Couture, S. Blanchard, R.A. Moats et al., Neural stem cell-mediated enzyme\/prodrug therapy for glioma: preclinical studies. Sci. Transl. Med. 5(184), 184ra159 (2013)","journal-title":"Sci. Transl. Med."},{"key":"842_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.addr.2017.09.003","volume":"118","author":"R Mooney","year":"2017","unstructured":"R. Mooney, A. Abdul Majid, J. Batalla, A.J. Annala, K.S. Aboody, Cell-mediated enzyme prodrug cancer therapies. Adv. Drug Deliv. Rev. 118, 35\u201351 (2017)","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"842_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"K. Takahashi, S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663\u2013676 (2006)","journal-title":"Cell"},{"issue":"5","key":"842_CR17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, S. Yamanaka, Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5), 861\u2013872 (2007)","journal-title":"Cell"},{"issue":"5\u20136","key":"842_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1089\/hum.2019.326","volume":"31","author":"R Tamura","year":"2020","unstructured":"R. Tamura, H. Miyoshi, Y. Morimoto, Y. Oishi, O. Sampetrean, C. Iwasawa, Y. Mine, H. Saya, K. Yoshida, H. Okano et al., Gene therapy using neural stem\/progenitor cells derived from human induced pluripotent stem cells: visualization of migration and bystander killing effect. Hum. Gene Ther. 31(5\u20136), 352\u2013366 (2020)","journal-title":"Hum. Gene Ther."},{"key":"842_CR19","doi-asserted-by":"crossref","unstructured":"J.R. Bag\u00f3, O. Okolie, R. Dumitru, M.G. Ewend, J.S. Parker, R.V. Werff, T.M. Underhill, R.S. Schmid, C.R. Miller, S.D. Hingtgen, Tumor-homing cytotoxic human induced neural stem cells for cancer therapy. Sci. Transl. Med. 9(375), (2017)","DOI":"10.1126\/scitranslmed.aah6510"},{"issue":"4","key":"842_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.stem.2012.03.003","volume":"10","author":"M Thier","year":"2012","unstructured":"M. Thier, P. W\u00f6rsd\u00f6rfer, Y.B. Lakes, R. Gorris, S. Herms, T. Opitz, D. Seiferling, T. Quandel, P. Hoffmann, M.M. N\u00f6then et al., Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell 10(4), 473\u2013479 (2012)","journal-title":"Cell Stem Cell"},{"issue":"7","key":"842_CR21","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1073\/pnas.1121003109","volume":"109","author":"E Lujan","year":"2012","unstructured":"E. Lujan, S. Chanda, H. Ahlenius, T.C. S\u00fcdhof, M. Wernig, Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc. Natl. Acad. Sci. U.S.A. 109(7), 2527\u20132532 (2012)","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"842_CR22","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/neuonc\/noz138","volume":"21","author":"AB Satterlee","year":"2019","unstructured":"A.B. Satterlee, D.E. Dunn, D.C. Lo, S. Khagi, S. Hingtgen, Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma. Neuro Oncol. 21(12), 1552\u20131564 (2019)","journal-title":"Neuro Oncol."},{"key":"842_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-31206-0_1","volume":"1201","author":"S Suman","year":"2019","unstructured":"S. Suman, A. Domingues, J. Ratajczak, M.Z. Ratajczak, Potential clinical applications of stem cells in regenerative medicine. Adv. Exp. Med. Biol. 1201, 1\u201322 (2019)","journal-title":"Adv. Exp. Med. Biol."},{"issue":"17","key":"842_CR24","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.7150\/thno.26643","volume":"8","author":"Y Yuan","year":"2018","unstructured":"Y. Yuan, X. Tang, Y.F. Bai, S. Wang, J. An, Y. Wu, Z.D. Xu, Y.A. Zhang, Z. Chen, Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson\u2019s disease model. Theranostics 8(17), 4679\u20134694 (2018)","journal-title":"Theranostics"},{"issue":"2","key":"842_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11912-020-01007-5","volume":"23","author":"AL Mende","year":"2021","unstructured":"A.L. Mende, J.D. Schulte, H. Okada, J.L. Clarke, Current Advances in Immunotherapy for Glioblastoma. Curr. Oncol. Rep. 23(2), 21 (2021)","journal-title":"Curr. Oncol. Rep."},{"key":"842_CR26","doi-asserted-by":"publisher","first-page":"676301","DOI":"10.3389\/fimmu.2021.676301","volume":"12","author":"MW Yu","year":"2021","unstructured":"M.W. Yu, D.F. Quail, Immunotherapy for glioblastoma: current progress and challenges. Front. Immunol. 12, 676301 (2021)","journal-title":"Front. Immunol."},{"key":"842_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fimmu.2019.00128","volume":"10","author":"M Martinez","year":"2019","unstructured":"M. Martinez, E.K. Moon, CAR T cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment. Front. Immunol. 10, 128 (2019)","journal-title":"Front. Immunol."},{"issue":"13","key":"842_CR28","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1158\/0008-5472.CAN-21-0035","volume":"81","author":"R Ma","year":"2021","unstructured":"R. Ma, T. Lu, Z. Li, K.Y. Teng, A.G. Mansour, M. Yu, L. Tian, B. Xu, S. Ma, J. Zhang et al., An oncolytic virus expressing IL15\/IL15R\u03b1 combined with Off-the-Shelf EGFR-CAR NK cells targets glioblastoma. Can. Res. 81(13), 3635\u20133648 (2021)","journal-title":"Can. Res."},{"issue":"1","key":"842_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41698-021-00233-9","volume":"5","author":"M Prapa","year":"2021","unstructured":"M. Prapa, C. Chiavelli, G. Golinelli, G. Grisendi, M. Bestagno, R. Di Tinco, M. Dall\u2019Ora, G. Neri, O. Candini, C. Spano et al., GD2 CAR T cells against human glioblastoma. NPJ Precis. Oncol. 5(1), 93 (2021)","journal-title":"NPJ Precis. Oncol."},{"key":"842_CR30","doi-asserted-by":"crossref","unstructured":"T. Gargett, L.M. Ebert, N.T.H. Truong, P.M. Kollis, K. Sedivakova, W. Yu, E.C.F. Yeo, N.L. Wittwer, B.L. Gliddon, M.N. Tea et al., GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma. J Immunother Cancer. 10(9), e005187 (2022)","DOI":"10.1136\/jitc-2022-005187"},{"key":"842_CR31","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.3389\/fimmu.2019.02683","volume":"10","author":"MC Burger","year":"2019","unstructured":"M.C. Burger, C. Zhang, P.N. Harter, A. Romanski, F. Strassheimer, C. Senft, T. Tonn, J.P. Steinbach, W.S. Wels, CAR-Engineered NK cells for the treatment of glioblastoma: turning innate effectors into precision tools for cancer immunotherapy. Front. Immunol. 10, 2683 (2019)","journal-title":"Front. Immunol."},{"issue":"20","key":"842_CR32","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1182\/blood.2020006619","volume":"136","author":"M Gang","year":"2020","unstructured":"M. Gang, N.D. Marin, P. Wong, C.C. Neal, L. Marsala, M. Foster, T. Schappe, W. Meng, J. Tran, M. Schaettler et al., CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas. Blood 136(20), 2308\u20132318 (2020)","journal-title":"Blood"},{"issue":"3","key":"842_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.molmed.2021.12.008","volume":"28","author":"A Balatsoukas","year":"2022","unstructured":"A. Balatsoukas, F. Rossignoli, K. Shah, NK cells in the brain: implications for brain tumor development and therapy. Trends Mol. Med. 28(3), 194\u2013209 (2022)","journal-title":"Trends Mol. Med."},{"issue":"18","key":"842_CR34","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.1158\/1078-0432.CCR-19-0916","volume":"25","author":"Y Zhao","year":"2019","unstructured":"Y. Zhao, Z. Liu, X. Wang, H. Wu, J. Zhang, J. Yang, F. Zhang, L. Liu, J. Long, P. Lu et al., Treatment with humanized selective CD19CAR-T cells shows efficacy in highly treated B-ALL patients who have relapsed after receiving murine-based CD19CAR-T therapies. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 25(18), 5595\u20135607 (2019)","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"5","key":"842_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/gt.2010.163","volume":"18","author":"S Charrier","year":"2011","unstructured":"S. Charrier, M. Ferrand, M. Zerbato, G. Pr\u00e9cigout, A. Viornery, S. Bucher-Laurent, S. Benkhelifa-Ziyyat, O.W. Merten, J. Perea, A. Galy, Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction. Gene Ther. 18(5), 479\u2013487 (2011)","journal-title":"Gene Ther."},{"key":"842_CR36","doi-asserted-by":"publisher","first-page":"10593","DOI":"10.1038\/ncomms10593","volume":"7","author":"JR Bago","year":"2016","unstructured":"J.R. Bago, A. Alfonso-Pecchio, O. Okolie, R. Dumitru, A. Rinkenbaugh, A.S. Baldwin, C.R. Miller, S.T. Magness, S.D. Hingtgen, Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma. Nat. Commun. 7, 10593 (2016)","journal-title":"Nat. Commun."},{"key":"842_CR37","doi-asserted-by":"crossref","unstructured":"C. Zhang, M.C. Burger, L. Jennewein, S. Gen\u00dfler, K. Sch\u00f6nfeld, P. Zeiner, E. Hattingen, P.N. Harter, M. Mittelbronn, T. Tonn et al., ErbB2\/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma. J Natl Cancer Inst. 108(5) (2016)","DOI":"10.1093\/jnci\/djv375"},{"issue":"1","key":"842_CR38","doi-asserted-by":"publisher","first-page":"1757360","DOI":"10.1080\/2162402X.2020.1757360","volume":"9","author":"S Murty","year":"2020","unstructured":"S. Murty, S.T. Haile, C. Beinat, A. Aalipour, I.S. Alam, T. Murty, T.M. Shaffer, C.B. Patel, E.E. Graves, C.L. Mackall et al., Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model. Oncoimmunology 9(1), 1757360 (2020)","journal-title":"Oncoimmunology"},{"issue":"12","key":"842_CR39","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1158\/1078-0432.CCR-16-1518","volume":"23","author":"J Portnow","year":"2017","unstructured":"J. Portnow, T.W. Synold, B. Badie, R. Tirughana, S.F. Lacey, M. D\u2019Apuzzo, M.Z. Metz, J. Najbauer, V. Bedell, T. Vo et al., Neural stem cell-based anticancer gene therapy: a first-in-human study in recurrent high-grade glioma patients. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 23(12), 2951\u20132960 (2017)","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"7","key":"842_CR40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/sctm.18-0039","volume":"8","author":"Y Kimura","year":"2019","unstructured":"Y. Kimura, T. Shofuda, Y. Higuchi, I. Nagamori, M. Oda, M. Nakamori, M. Onodera, D. Kanematsu, A. Yamamoto, A. Katsuma et al., Human genomic safe harbors and the suicide gene-based safeguard system for iPSC-Based cell therapy. Stem Cells Transl. Med. 8(7), 627\u2013638 (2019)","journal-title":"Stem Cells Transl. Med."},{"issue":"9","key":"842_CR41","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41590-019-0433-y","volume":"20","author":"CM Jackson","year":"2019","unstructured":"C.M. Jackson, J. Choi, M. Lim, Mechanisms of immunotherapy resistance: lessons from glioblastoma. Nat. Immunol. 20(9), 1100\u20131109 (2019)","journal-title":"Nat. Immunol."},{"key":"842_CR42","doi-asserted-by":"crossref","unstructured":"D.M. O'Rourke, M.P. Nasrallah, A. Desai, J.J. Melenhorst, K. Mansfield, J.J.D. Morrissette, M. Martinez-Lage, S. Brem, E. Maloney, A. Shen et al., A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Sci Transl Med. 9(399), eaaa0984 (2017)","DOI":"10.1126\/scitranslmed.aaa0984"},{"issue":"4","key":"842_CR43","first-page":"126","volume":"42","author":"SL Goff","year":"2019","unstructured":"S.L. Goff, R.A. Morgan, J.C. Yang, R.M. Sherry, P.F. Robbins, N.P. Restifo, S.A. Feldman, Y.C. Lu, L. Lu, Z. Zheng et al., Pilot trial of adoptive transfer of chimeric antigen receptor-transduced T cells targeting EGFRvIII in patients with glioblastoma. J. Immunother. (Hagerstown, Md\u202f: 1997) 42(4), 126\u2013135 (2019)","journal-title":"J. Immunother. (Hagerstown, Md : 1997)"},{"key":"842_CR44","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fimmu.2017.00533","volume":"8","author":"C Zhang","year":"2017","unstructured":"C. Zhang, P. Oberoi, S. Oelsner, A. Waldmann, A. Lindner, T. Tonn, W.S. Wels, Chimeric antigen receptor-engineered NK-92 cells: an off-the-shelf cellular therapeutic for targeted elimination of cancer cells and induction of protective antitumor immunity. Front. Immunol. 8, 533 (2017)","journal-title":"Front. Immunol."},{"key":"842_CR45","doi-asserted-by":"crossref","unstructured":"M. Chrobok, C.I.M. Dahlberg, E.C. Sayitoglu, V. Beljanski, H. Nahi, M. Gilljam, B. Stellan, T. Sutlu, A.D. Duru, E. Alici., Functional assessment for clinical use of serum-free adapted NK-92 cells. Cancers (Basel).\n11(1), 69 (2019)","DOI":"10.3390\/cancers11010069"},{"issue":"6","key":"842_CR46","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/14653240802301872","volume":"10","author":"S Arai","year":"2008","unstructured":"S. Arai, R. Meagher, M. Swearingen, H. Myint, E. Rich, J. Martinson, H. Klingemann, Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial. Cytotherapy 10(6), 625\u2013632 (2008)","journal-title":"Cytotherapy"},{"issue":"1","key":"842_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10143-019-01203-3","volume":"44","author":"R Tamura","year":"2021","unstructured":"R. Tamura, H. Miyoshi, K. Yoshida, H. Okano, M. Toda, Recent progress in the research of suicide gene therapy for malignant glioma. Neurosurg. Rev. 44(1), 29\u201349 (2021)","journal-title":"Neurosurg. Rev."},{"issue":"12","key":"842_CR48","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/sj.gt.3300784","volume":"5","author":"RL Touraine","year":"1998","unstructured":"R.L. Touraine, H. Ishii-Morita, W.J. Ramsey, R.M. Blaese, The bystander effect in the HSVtk\/ganciclovir system and its relationship to gap junctional communication. Gene Ther. 5(12), 1705\u20131711 (1998)","journal-title":"Gene Ther."},{"key":"842_CR49","doi-asserted-by":"publisher","first-page":"174957","DOI":"10.1016\/j.ejphar.2022.174957","volume":"924","author":"P Maleki Dana","year":"2022","unstructured":"P. Maleki Dana, F. Sadoughi, H. Mirzaei, Z. Asemi, B. Yousefi, DNA damage response and repair in the development and treatment of brain tumors. Eur. J. Pharmacol. 924, 174957 (2022)","journal-title":"Eur. J. Pharmacol."},{"issue":"7120","key":"842_CR50","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"S. Bao, Q. Wu, R.E. McLendon, Y. Hao, Q. Shi, A.B. Hjelmeland, M.W. Dewhirst, D.D. Bigner, J.N. Rich, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120), 756\u2013760 (2006)","journal-title":"Nature"},{"key":"842_CR51","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.3389\/fimmu.2019.02873","volume":"10","author":"ABL Colamartino","year":"2019","unstructured":"A.B.L. Colamartino, W. Lemieux, P. Bifsha, S. Nicoletti, N. Chakravarti, J. Sanz, H. Rom\u00e9ro, S. Selleri, K. B\u00e9land, M. Guiot et al., Efficient and robust NK-Cell transduction with baboon envelope Pseudotyped Lentivector. Front. Immunol. 10, 2873 (2019)","journal-title":"Front. Immunol."},{"issue":"5","key":"842_CR52","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1021\/jacs.8b10286","volume":"141","author":"Y Ge","year":"2019","unstructured":"Y. Ge, L. Chen, S. Liu, J. Zhao, H. Zhang, P.R. Chen, Enzyme-mediated intercellular proximity labeling for detecting cell-cell interactions. J. Am. Chem. Soc. 141(5), 1833\u20131837 (2019)","journal-title":"J. Am. Chem. Soc."},{"issue":"13","key":"842_CR53","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1158\/1078-0432.CCR-09-0155","volume":"15","author":"M Candolfi","year":"2009","unstructured":"M. Candolfi, K. Yagiz, D. Foulad, G.E. Alzadeh, M. Tesarfreund, A.K. Muhammad, M. Puntel, K.M. Kroeger, C. Liu, S. Lee et al., Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity. Clin. Cancer Res: Off. J Am. Assoc. Cancer Res. 15(13), 4401\u20134414 (2009)","journal-title":"Clin. Cancer Res: Off. J Am. Assoc. Cancer Res."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-023-00842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-023-00842-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-023-00842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T03:08:26Z","timestamp":1701832106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-023-00842-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["842"],"URL":"https:\/\/doi.org\/10.1007\/s13402-023-00842-5","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"assertion":[{"value":"28 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All Procedures performed in studies involving animals were approved by the Ethics Committee of Xuanwu hospital capital medical university. All the mouse experimental procedures were performed according to the protocols approved by the Xuanwu hospital capital medical university Experimental Animal Care Commission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}